If the shares are authorized I consider them issued.
Just my experience being conservative in small cap biotechs. I'm also in Cytodyn and they just authorized another 100M so I consider their outstanding to be 800M instead of 700M.
Humanigen authorizing another 525M has definitely caused me to reassess my strategy as an investor. I'm now in for the Covid results only and it's become a lot more of a gamble because I don't like the valuation long term given the amount of new shares authorized.